Pfizer Prepares For Year-End US Bevacizumab Launch

 
• By Aidan Fry
  
Jumping
Pfizer will enter 2020 on the back of launching its Zirabev becacizumab biosimilar in the US on 31 December • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products